You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 12, Issue 3

March 2020 - 246 articles

Cover Story: Breast cancer (BC) is the most common cancer in women worldwide. Approximately 70–80% of BCs express estrogen receptors (ER) and are, therefore, hormone receptor-positive (HR+). Endogenous cannabinoids together with cannabinoid receptor 1 and 2 (CB1, CB2) constitute the basis of the endocannabinoid system and interactions of cannabinoids with hypothalamic-pituitary-gonadal axis hormones are well documented. Do cannabinoids have an effect on HR+ BC? In most preclinical studies, CB1 and CB2 agonists (i.e., anandamide, THC) have been shown to inhibit the proliferation of ER-positive BC cell lines. There is less evidence for antitumor cannabinoid action in HR+ BC in animal models and no clinical trials are exploring the effects of cannabinoids on HR+ BC treatment outcomes. In this paper, we review known and possible interactions between cannabinoids and specific HR+ BC treatments. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (246)

  • Article
  • Open Access
21 Citations
4,969 Views
12 Pages

Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis

  • Aya Takahashi,
  • Michihisa Moriguchi,
  • Yuya Seko,
  • Toshihide Shima,
  • Yasuhide Mitsumoto,
  • Hidetaka Takashima,
  • Hiroyuki Kimura,
  • Hideki Fujii,
  • Hiroki Ishikawa and
  • Takaharu Yo
  • + 16 authors

23 March 2020

We investigated the association between early tumor shrinkage (ETS) and treatment outcome in patients with hepatocellular carcinoma treated with lenvatinib (LEN). A retrospective analysis was performed in 104 patients. ETS was defined as tumor shrink...

  • Article
  • Open Access
12 Citations
5,116 Views
17 Pages

Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma

  • Lovely Raghav,
  • Ya-Hsuan Chang,
  • Yi-Chiung Hsu,
  • Yu-Cheng Li,
  • Chih-Yi Chen,
  • Tsung-Ying Yang,
  • Kun-Chieh Chen,
  • Kuo-Hsuan Hsu,
  • Jeng-Sen Tseng and
  • Cheng-Yen Chuang
  • + 12 authors

23 March 2020

Risk factors including genetic effects are still being investigated in lung adenocarcinoma (LUAD). Mitochondria play an important role in controlling imperative cellular parameters, and anomalies in mitochondrial function might be crucial for cancer...

  • Article
  • Open Access
28 Citations
6,247 Views
25 Pages

Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid

  • Mariah M. Hoffman,
  • Jessica S. Zylla,
  • Somshuvra Bhattacharya,
  • Kristin Calar,
  • Timothy W. Hartman,
  • Ratan D. Bhardwaj,
  • W. Keith Miskimins,
  • Pilar de la Puente,
  • Etienne Z. Gnimpieba and
  • Shanta M. Messerli

23 March 2020

Central nervous system atypical teratoid/rhabdoid tumors (ATRTs) are rare and aggressive tumors with a very poor prognosis. Current treatments for ATRT include resection of the tumor, followed by systemic chemotherapy and radiation therapy, which hav...

  • Article
  • Open Access
29 Citations
4,888 Views
18 Pages

23 March 2020

Background: Recurrence and distant organ metastasis is a major cause of death in colorectal cancer (CRC); however, the underlying molecular mechanisms regulating this phenomenon are poorly understood. MeCP2 is a key epigenetic regulator and is amplif...

  • Article
  • Open Access
27 Citations
8,950 Views
9 Pages

LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications

  • Eytan Ben-Ami,
  • Raul Perret,
  • Ying Huang,
  • Félicie Courgeon,
  • Prafulla C. Gokhale,
  • Audrey Laroche-Clary,
  • Benjamin K. Eschle,
  • Valérie Velasco,
  • François Le Loarer and
  • Marie-Paule Algeo
  • + 3 authors

23 March 2020

Background: LRRC15 is a member of the LRR (leucine-rich repeat) superfamily present on tumor-associated fibroblasts (CAFs) and stromal cells. The expression of LRRC15 is upregulated by the pro-inflammatory cytokine TGFβ. ABBV-085 is a monomethyl...

  • Article
  • Open Access
23 Citations
4,065 Views
16 Pages

23 March 2020

New microRNA-based serum biomarkers (miRNA-367-3p, -371a-3p, -372-3p, and -373-3p) have shown great potential for the detection of testicular germ cell tumors (TGCTs), but few studies have investigated the clinical utility and performance of these te...

  • Article
  • Open Access
10 Citations
3,732 Views
18 Pages

CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males

  • Cassy M. Spiller,
  • João Lobo,
  • Willem P. A. Boellaard,
  • Ad J. M. Gillis,
  • Josephine Bowles and
  • Leendert H. J. Looijenga

23 March 2020

miR-371a-3p is currently the most informative reported biomarker for germ cell tumors (GCTs). Another developmental-related biomarker, CRIPTO, is involved in the regulation of pluripotency and germ cell fate commitment. We aimed to assess the value o...

  • Review
  • Open Access
47 Citations
9,094 Views
16 Pages

Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer

  • Manuel Regouc,
  • Gazanfer Belge,
  • Anja Lorch,
  • Klaus-Peter Dieckmann and
  • Martin Pichler

22 March 2020

Testicular cancer is an important disease with increasing incidence and a high burden of morbidity and mortality in young men worldwide. Histological examination of the testicular tissue after orchiectomy plays an important role alongside patient his...

  • Article
  • Open Access
31 Citations
4,861 Views
15 Pages

Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth

  • Husain Yar Khan,
  • Gabriel B. Mpilla,
  • Rachel Sexton,
  • Srikant Viswanadha,
  • Kumar V. Penmetsa,
  • Amro Aboukameel,
  • Maria Diab,
  • Mandana Kamgar,
  • Mohammed Najeeb Al-Hallak and
  • Mark Szlaczky
  • + 5 authors

22 March 2020

Pancreatic ductal adenocarcinoma (PDAC) remains an unmet clinical problem in urgent need of newer molecularly driven treatment modalities. Calcium signals, particularly those associated with calcium release-activated calcium (CRAC) channels, are know...

  • Perspective
  • Open Access
80 Citations
7,258 Views
20 Pages

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives

  • Bas Weenink,
  • Pim J. French,
  • Peter A.E. Sillevis Smitt,
  • Reno Debets and
  • Marjolein Geurts

22 March 2020

Glioblastomas are aggressive, fast-growing primary brain tumors. After standard-of-care treatment with radiation in combination with temozolomide, the overall prognosis of newly diagnosed patients remains poor, with a 2-year survival rate of less tha...

of 25

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694